Trial
NCT03733249
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bellicum Pharmaceuticals
Collaborators
—
Condition
Acute Lymphoblastic Leukemia
Intervention
Rimiducid
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-26